The ACLT group exhibited reduced expression of PPAR‐γ, GLUT1, aggrecan, and collagen II, alongside increased collagen I expression, indicating chondrocyte metabolic disorders and phenotypic loss (Figure 7D–H). Here, SLC2A1 is linked to metabolic disease.